Radboud Univeristy Medical Centre
Welcome,         Profile    Billing    Logout  
 6 Trials 
13 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Marx, Gavin
P3BEP, NCT02582697 / 2015-003060-37 / ACTRN12613000496718: Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Recruiting
3
500
US, RoW
Bleomycin (active name: Bleomycin Sulfate), Blenamax (Aspen), DBL Bleomycin Sulphate (Willow Pharmaceuticals Pty Limited), Bleo Powder for injection (Hospira), Etoposide, DBL Etoposide Injection (Hospira), Etopophos (Bristol-Myers Squibb), Etoposide (Pfizer), Etoposide Ebewe (Sandoz), Cisplatin, Cisplatin Ebewe (Sandoz), Cisplatin injection (Pfizer), DBL Cisplatin Injection (Hospira), Pegylated G-CSF (Pegfilgrastim), Neulasta Syringe with Automatic Needle Guard (Amgen), Filgrastim, Neupogen (Amgen), Nivestim (Hospira), Tevagrastim (Teva Pharma Australia Pty Ltd), Zarzio (Sandoz)
University of Sydney, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Cambridge University Hospitals NHS Foundation Trust, Cancer Trials Ireland, Children's Oncology Group, Dana-Farber Cancer Institute, University of Southern California
Intermediate and poor-risk metastatic germ cell tumours (GCTs)
02/22
07/23
PANOVA-3, NCT03377491: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel

Completed
3
571
Europe, Canada, US, RoW
NovoTTF-200T, TTFields, Gemcitabine, nab paclitaxel
NovoCure Ltd.
Pancreas Adenocarcinoma
10/24
10/24
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting
3
496
Europe, US, RoW
Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone
Jiangsu HengRui Medicine Co., Ltd.
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
12/26
12/26
ACTRN12607000307404: A phase II trial of docetaxel (Taxotere) in combination with PI88 for men with androgen independent prostate cancer

Recruiting
2
82
 
 
 
ACTRN12606000372583: A study evaluating the role of docetaxel (Taxotere) in combination with thalidomide in men with hormone refractory prostate cancer

Active, not recruiting
2
35
 
Royal North Shore Hospital, Educational grant from Sanofi Aventis, Educational grant from Pharmion, Cancer Trials NSW
Prostate cancer
 
 
WOMBAT, NCT06594926: Working Out M0 Bipolar Androgen Therapy

Recruiting
2
69
RoW
Testosterone Enanthate, Primoteston Depot
Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Bayer, The George Institute, HMRI
Prostate Cancer
12/26
12/28
ANZadapt, NCT05393791: Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

Recruiting
2
168
Europe, RoW
Patient-specific adaptive therapy, Abiraterone acetate, Zytiga, Enzalutamide, Xtandi
Leiden University Medical Center, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Anticancer Fund, Belgium
Prostatic Neoplasms, Castration-Resistant
11/27
11/27
SYS-CAPLIOX, NCT04701281: Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer

Recruiting
1/2
95
RoW
Intra-arterial LIOX + Capecitabine
AllVascular
Liver Metastasis Colon Cancer
07/23
07/23
HRS-5041-103, NCT06830850: A Trial of to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

Not yet recruiting
1
25
RoW
HRS-5041 Single dose of HRS-5041 orally administered
Atridia Pty Ltd.
Metastatic Castration Resistant Prostate Cancer
12/26
03/27
NCT00819208: Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

Active, not recruiting
N/A
889
Europe, Canada, US, RoW
exercise intervention, counseling intervention, educational intervention, laboratory biomarker analysis, questionnaire administration, study of socioeconomic and demographic variables, fatigue assessment and management, quality-of-life assessment, Educational Intervention, Fitness testing
Canadian Cancer Trials Group, Survivorship Research Group, Queen's University, Belfast
Anxiety Disorder, Cognitive/Functional Effects, Colorectal Cancer, Depression, Fatigue, Psychosocial Effects of Cancer and Its Treatment, Sleep Disorders, Excercise
12/29
12/30
Oort, Inge van
REDOSE, NCT03927391: Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects

Completed
4
57
Europe
Enzalutamide
Radboud University Medical Center
Prostatic Neoplasms, Castration-Resistant
01/24
01/24
ANZadapt, NCT05393791: Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

Recruiting
2
168
Europe, RoW
Patient-specific adaptive therapy, Abiraterone acetate, Zytiga, Enzalutamide, Xtandi
Leiden University Medical Center, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Anticancer Fund, Belgium
Prostatic Neoplasms, Castration-Resistant
11/27
11/27
MIND THE GAP, NCT05339672: Determining the Clinical Relevance of the Interaction Between Enzalutamide and the Opioid Morphine and the DOAC Edoxaban

Recruiting
N/A
26
Europe
Blood sampling - Pharmacokinetic assessment
Radboud University Medical Center, Astellas Pharma Inc
Drug-drug Interaction
08/24
08/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Marx, Gavin
P3BEP, NCT02582697 / 2015-003060-37 / ACTRN12613000496718: Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Recruiting
3
500
US, RoW
Bleomycin (active name: Bleomycin Sulfate), Blenamax (Aspen), DBL Bleomycin Sulphate (Willow Pharmaceuticals Pty Limited), Bleo Powder for injection (Hospira), Etoposide, DBL Etoposide Injection (Hospira), Etopophos (Bristol-Myers Squibb), Etoposide (Pfizer), Etoposide Ebewe (Sandoz), Cisplatin, Cisplatin Ebewe (Sandoz), Cisplatin injection (Pfizer), DBL Cisplatin Injection (Hospira), Pegylated G-CSF (Pegfilgrastim), Neulasta Syringe with Automatic Needle Guard (Amgen), Filgrastim, Neupogen (Amgen), Nivestim (Hospira), Tevagrastim (Teva Pharma Australia Pty Ltd), Zarzio (Sandoz)
University of Sydney, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Cambridge University Hospitals NHS Foundation Trust, Cancer Trials Ireland, Children's Oncology Group, Dana-Farber Cancer Institute, University of Southern California
Intermediate and poor-risk metastatic germ cell tumours (GCTs)
02/22
07/23
PANOVA-3, NCT03377491: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel

Completed
3
571
Europe, Canada, US, RoW
NovoTTF-200T, TTFields, Gemcitabine, nab paclitaxel
NovoCure Ltd.
Pancreas Adenocarcinoma
10/24
10/24
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting
3
496
Europe, US, RoW
Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone
Jiangsu HengRui Medicine Co., Ltd.
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
12/26
12/26
ACTRN12607000307404: A phase II trial of docetaxel (Taxotere) in combination with PI88 for men with androgen independent prostate cancer

Recruiting
2
82
 
 
 
ACTRN12606000372583: A study evaluating the role of docetaxel (Taxotere) in combination with thalidomide in men with hormone refractory prostate cancer

Active, not recruiting
2
35
 
Royal North Shore Hospital, Educational grant from Sanofi Aventis, Educational grant from Pharmion, Cancer Trials NSW
Prostate cancer
 
 
WOMBAT, NCT06594926: Working Out M0 Bipolar Androgen Therapy

Recruiting
2
69
RoW
Testosterone Enanthate, Primoteston Depot
Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Bayer, The George Institute, HMRI
Prostate Cancer
12/26
12/28
ANZadapt, NCT05393791: Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

Recruiting
2
168
Europe, RoW
Patient-specific adaptive therapy, Abiraterone acetate, Zytiga, Enzalutamide, Xtandi
Leiden University Medical Center, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Anticancer Fund, Belgium
Prostatic Neoplasms, Castration-Resistant
11/27
11/27
SYS-CAPLIOX, NCT04701281: Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer

Recruiting
1/2
95
RoW
Intra-arterial LIOX + Capecitabine
AllVascular
Liver Metastasis Colon Cancer
07/23
07/23
HRS-5041-103, NCT06830850: A Trial of to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

Not yet recruiting
1
25
RoW
HRS-5041 Single dose of HRS-5041 orally administered
Atridia Pty Ltd.
Metastatic Castration Resistant Prostate Cancer
12/26
03/27
NCT00819208: Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

Active, not recruiting
N/A
889
Europe, Canada, US, RoW
exercise intervention, counseling intervention, educational intervention, laboratory biomarker analysis, questionnaire administration, study of socioeconomic and demographic variables, fatigue assessment and management, quality-of-life assessment, Educational Intervention, Fitness testing
Canadian Cancer Trials Group, Survivorship Research Group, Queen's University, Belfast
Anxiety Disorder, Cognitive/Functional Effects, Colorectal Cancer, Depression, Fatigue, Psychosocial Effects of Cancer and Its Treatment, Sleep Disorders, Excercise
12/29
12/30
Oort, Inge van
REDOSE, NCT03927391: Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects

Completed
4
57
Europe
Enzalutamide
Radboud University Medical Center
Prostatic Neoplasms, Castration-Resistant
01/24
01/24
ANZadapt, NCT05393791: Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

Recruiting
2
168
Europe, RoW
Patient-specific adaptive therapy, Abiraterone acetate, Zytiga, Enzalutamide, Xtandi
Leiden University Medical Center, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Anticancer Fund, Belgium
Prostatic Neoplasms, Castration-Resistant
11/27
11/27
MIND THE GAP, NCT05339672: Determining the Clinical Relevance of the Interaction Between Enzalutamide and the Opioid Morphine and the DOAC Edoxaban

Recruiting
N/A
26
Europe
Blood sampling - Pharmacokinetic assessment
Radboud University Medical Center, Astellas Pharma Inc
Drug-drug Interaction
08/24
08/24

Download Options